Drug Companies Block Shareholders’ Voting on Price Transparency

Several major U.S. drug companies, including Pfizer and Merck, have squelched an investor campaign aimed at forcing companies to disclose more information about when and why they raise prices. All images and written content is property of the listed RSS FEED if you would like more on this story and images please click the listed feed. http://www.wsj.com/xml/rss/3_7014.xml

Leave a Reply